Surgery Partners, Inc.
SGRY
$21.48
-$0.36-1.65%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.20% | 1.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.20% | 1.09% | |||
| Cost of Revenue | 6.39% | 1.72% | |||
| Gross Profit | 31.61% | -0.95% | |||
| SG&A Expenses | 23.29% | -27.54% | |||
| Depreciation & Amortization | -32.47% | 44.25% | |||
| Other Operating Expenses | -322.73% | 66.15% | |||
| Total Operating Expenses | 3.18% | 2.85% | |||
| Operating Income | 72.48% | -9.31% | |||
| Income Before Tax | 580.73% | -67.27% | |||
| Income Tax Expenses | 2,584.44% | -8.16% | |||
| Earnings from Continuing Operations | -828.13% | -77.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -62.47% | 13.21% | |||
| Net Income | -242.27% | -104.52% | |||
| EBIT | 72.48% | -9.31% | |||
| EBITDA | 37.48% | 3.51% | |||
| EPS Basic | -242.24% | -104.39% | |||
| Normalized Basic EPS | 618.15% | 19.16% | |||
| EPS Diluted | -242.24% | -104.39% | |||
| Normalized Diluted EPS | 618.15% | 19.16% | |||
| Average Basic Shares Outstanding | 0.03% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.03% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||